Endoscopic calcaneoplasty (ECP) as a surgical treatment of Haglund's syndrome

Joerg Jerosch1, J Schunck, S H Sokkar

  • 1Department for Orthopedic Surgery, Johanna-Etienne-Hospital, Am Hasenberg 46, 41462 Neuss, Germany. j.jerosch@jek-neuss.de

Insights

Endoscopic calcaneoplasty (ECP) offers an effective, minimally invasive treatment for posterior calcaneal exostosis. This technique shows superior outcomes and fewer complications compared to traditional open surgery.

Area of Science:

  • Orthopedic Surgery
  • Minimally Invasive Procedures

Background:

  • Posterior calcaneal exostosis treatment remains controversial.
  • Open surgical resection often yields unsatisfactory results and complications.
  • Endoscopic calcaneoplasty (ECP) presents a potential alternative.

Purpose of the Study:

  • To evaluate the efficacy and safety of endoscopic calcaneoplasty (ECP) for posterior calcaneal exostosis.
  • To compare ECP outcomes with traditional surgical methods.

Main Methods:

  • 81 patients (25-55 years) with posterior superior calcaneal exostosis underwent ECP.
  • All patients had failed conservative treatment for at least 6 months.
  • Radiographic and clinical assessments were performed, with an average follow-up of 35.3 months.

Main Results:

  • Excellent or good results were achieved in 82 out of 81 patients (98.7%) based on the Ogilvie-Harris-Score.
  • Postoperative radiographs confirmed sufficient spur resection.
  • Only minor postoperative complications were observed.

Conclusions:

  • Endoscopic calcaneoplasty (ECP) is an effective minimally invasive procedure for treating calcaneal exostosis.
  • ECP demonstrates advantages over open techniques, including reduced morbidity, shorter operating time, and minimal complications.
  • The endoscopic approach allows for better differentiation of pathology.